Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
14.26
-0.14 (-0.97%)
At close: Feb 13, 2026, 4:00 PM EST
14.25
-0.01 (-0.07%)
After-hours: Feb 13, 2026, 6:40 PM EST
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $263.99 million as of February 13, 2026. Its market cap has increased by 221.55% in one year.
Market Cap
263.99M
Enterprise Value
152.93M
1-Year Change
221.55%
Ranking
Category
Stock Price
$14.26
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $263.99M, an increase of 665.19%. That is a compound annual growth rate of 21.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 258.60M | -21.47% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 272.38M |
| Abeona Therapeutics | 271.50M |
| Cellectis | 269.89M |
| Fennec Pharmaceuticals | 264.69M |
| Minerva Neurosciences | 264.41M |
| Nautilus Biotechnology | 263.35M |
| Sutro Biopharma | 258.93M |
| Neurogene | 258.68M |